GlassScriptPhysician profile
Frederick Joseph Snoy
NPI 1518068535
$1,693.76
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,428 · 2020: $37.56 · 2021: $55.50 · 2022: $112 · 2023: $59.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $59.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $59.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,244.71 | 2019-2022 | |
| Astellas Pharma US INC | $212.73 | 2019-2023 | Xtandi |
| 180 Medical, INC. | $40.98 | 2022 | |
| Janssen Biotech, INC. | $33.57 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $29.28 | 2019 | |
| Boston Scientific Corporation | $25.08 | 2019 | |
| Endo Pharmaceuticals INC. | $22.22 | 2022 | |
| Progenics Pharmaceuticals, INC. | $18.51 | 2022 | |
| Astellas Pharma Global Development | $18.36 | 2020 | |
| Medtronic USA, INC. | $17.55 | 2019 | |
| Sumitomo Pharma America, INC. | $16.98 | 2023 | Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $13.79 | 2022 |
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Snoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.